These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7861918)

  • 21. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapses after fixed duration multiple drug therapy: the AMFES cohort.
    Gebre S; Saunderson P; Byass P
    Lepr Rev; 2000 Sep; 71(3):325-31. PubMed ID: 11105491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Priorities for the future and prospects for leprosy control.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
    [No Abstract]   [Full Text] [Related]  

  • 25. Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Lepr Rev; 2000 Jun; 71(2):193-205. PubMed ID: 10920614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study.
    Lugão HB; Frade MA; Marques W; Foss NT; Nogueira-Barbosa MH
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005111. PubMed ID: 27851766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
    Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY; Hu LF; Wu PW; Luo JS; Liu XM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed duration MDT in paucibacillary leprosy (classical and modified).
    Nadkarni NJ; Grugni A; Kini MS
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Kempen JH; Rao PS; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 Aug; 90(8):949-54. PubMed ID: 16707521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study).
    Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2000 Mar; 71(1):18-33. PubMed ID: 10820984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
    Vijayakumaran P; Jesudasan K; Manimozhi N
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relapse of leprosy after multidrug therapy.
    Dasananjali K
    J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of multiple drug therapy on leprosy disabilities.
    Willcox ML
    Lepr Rev; 1997 Dec; 68(4):350-66. PubMed ID: 9503872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.
    Daniel E; Ffytche TJ; Sundar Rao PS; Kempen JH; Diener-West M; Courtright P
    Br J Ophthalmol; 2006 May; 90(5):568-73. PubMed ID: 16622085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.